Clinical trial
Trial to Compare the Efficacy and Safety of Levocetirizine 5 mg od and Fexofenadine 120 mg od in Reducing Symptoms of Seasonal Allergic Rhinitis in Grass Pollen Sensitized Adults
NCT00542607 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Trial to Compare the Efficacy and Safety of Levocetirizine 5 mg od and Fexofenadine 120 mg od in Reducing Symptoms of Seasonal Allergic Rhinitis in Grass Pollen Sensitized Adults
- Lead sponsor
- UCB Pharma
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2002
- Completion date
- December 31, 2002
- Enrollment
- 94 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.